FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132308708> ?p ?o ?g. }

• W2132308708 endingPage "3212" @default.
• W2132308708 startingPage "3206" @default.
• W2132308708 abstract "Hepatocellular carcinoma (HCC) is characterized by the aberrant expression of a number of genes that govern crucial signaling pathways. The insulin‑like growth factor (IGF) axis is important in this context, and the precise regulation of expression of members of this axis is known to be lost in HCC. miR‑155 is a well‑established oncogene in numerous types of cancer. However, to the best of our knowledge, its effect on the regulation of the IGF axis has not been investigated to date. The present study aimed to elucidate the interactions between miR‑155 and key components of the IGF axis, in addition to examining its effect on HCC development. Reverse transcription‑quantitative polymerase chain reaction was used to measure the expression of miR‑155 in HCC and cirrhotic tissues, in addition to HCC cell lines. Furthermore, the effect of the induction of miR‑155 expression on the expression of three members of the IGF axis [IGF II, IGF type‑1 receptor (IGF‑1R) and IGF‑binding protein 3 (IGFBP‑3)], was analyzed. Finally, the effect of miR‑155 on HCC cell proliferation, migration and clonogenicity was also examined. Quantification of the expression of miR‑155 demonstrated that it is upregulated in HCC. Induction of the expression of miR‑155 in HCC cell lines led to the upregulation of IGF‑II and IGF‑IR, and the downregulation of IGFBP‑3. In addition, the proliferation, migration and clonogenicity of HCC was increased following induction of miR‑155 expression. miR‑155 is an oncomiR, which upregulates the oncogenes, IGF‑II and IGF‑IR, and downregulates the tumor suppressor, IGFBP‑3, thereby resulting in increased HCC cell carcinogenicity. Therefore, miR-155 may be a therapeutic target in HCC." @default.
• W2132308708 created "2016-06-24" @default.
• W2132308708 creator A5009311562 @default.
• W2132308708 creator A5011137431 @default.
• W2132308708 creator A5025034119 @default.
• W2132308708 creator A5036744055 @default.
• W2132308708 creator A5081593160 @default.
• W2132308708 creator A5082721751 @default.
• W2132308708 date "2015-09-18" @default.
• W2132308708 modified "2023-10-01" @default.
• W2132308708 title "Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma" @default.
• W2132308708 cites W144679933 @default.
• W2132308708 cites W1532583795 @default.
• W2132308708 cites W1565503905 @default.
• W2132308708 cites W1966749076 @default.
• W2132308708 cites W1967007963 @default.
• W2132308708 cites W1976628534 @default.
• W2132308708 cites W1980268451 @default.
• W2132308708 cites W1987287179 @default.
• W2132308708 cites W1987851658 @default.
• W2132308708 cites W1990576890 @default.
• W2132308708 cites W1993415234 @default.
• W2132308708 cites W1999355130 @default.
• W2132308708 cites W2004272510 @default.
• W2132308708 cites W2007725123 @default.
• W2132308708 cites W2021222588 @default.
• W2132308708 cites W2031415426 @default.
• W2132308708 cites W2048251248 @default.
• W2132308708 cites W2068931651 @default.
• W2132308708 cites W2069675870 @default.
• W2132308708 cites W2070917705 @default.
• W2132308708 cites W2072442043 @default.
• W2132308708 cites W2076278549 @default.
• W2132308708 cites W2077956417 @default.
• W2132308708 cites W2089171551 @default.
• W2132308708 cites W2092035608 @default.
• W2132308708 cites W2102824849 @default.
• W2132308708 cites W2106821690 @default.
• W2132308708 cites W2107515690 @default.
• W2132308708 cites W2108669962 @default.
• W2132308708 cites W2115441328 @default.
• W2132308708 cites W2119351122 @default.
• W2132308708 cites W2126104228 @default.
• W2132308708 cites W2134353492 @default.
• W2132308708 cites W2139513420 @default.
• W2132308708 cites W2144978065 @default.
• W2132308708 cites W2158386218 @default.
• W2132308708 cites W2160835537 @default.
• W2132308708 cites W2163106706 @default.
• W2132308708 cites W3140002906 @default.
• W2132308708 cites W4235541467 @default.
• W2132308708 doi "https://doi.org/10.3892/ol.2015.3725" @default.
• W2132308708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4665895" @default.
• W2132308708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26722313" @default.
• W2132308708 hasPublicationYear "2015" @default.
• W2132308708 type Work @default.
• W2132308708 sameAs 2132308708 @default.
• W2132308708 citedByCount "19" @default.
• W2132308708 countsByYear W21323087082016 @default.
• W2132308708 countsByYear W21323087082018 @default.
• W2132308708 countsByYear W21323087082019 @default.
• W2132308708 countsByYear W21323087082020 @default.
• W2132308708 countsByYear W21323087082021 @default.
• W2132308708 countsByYear W21323087082022 @default.
• W2132308708 countsByYear W21323087082023 @default.
• W2132308708 crossrefType "journal-article" @default.
• W2132308708 hasAuthorship W2132308708A5009311562 @default.
• W2132308708 hasAuthorship W2132308708A5011137431 @default.
• W2132308708 hasAuthorship W2132308708A5025034119 @default.
• W2132308708 hasAuthorship W2132308708A5036744055 @default.
• W2132308708 hasAuthorship W2132308708A5081593160 @default.
• W2132308708 hasAuthorship W2132308708A5082721751 @default.
• W2132308708 hasBestOaLocation W21323087081 @default.
• W2132308708 hasConcept C104317684 @default.
• W2132308708 hasConcept C127561419 @default.
• W2132308708 hasConcept C145059251 @default.
• W2132308708 hasConcept C1491633281 @default.
• W2132308708 hasConcept C2778455985 @default.
• W2132308708 hasConcept C2781018059 @default.
• W2132308708 hasConcept C29537977 @default.
• W2132308708 hasConcept C39845236 @default.
• W2132308708 hasConcept C502942594 @default.
• W2132308708 hasConcept C54355233 @default.
• W2132308708 hasConcept C62112901 @default.
• W2132308708 hasConcept C86803240 @default.
• W2132308708 hasConceptScore W2132308708C104317684 @default.
• W2132308708 hasConceptScore W2132308708C127561419 @default.
• W2132308708 hasConceptScore W2132308708C145059251 @default.
• W2132308708 hasConceptScore W2132308708C1491633281 @default.
• W2132308708 hasConceptScore W2132308708C2778455985 @default.
• W2132308708 hasConceptScore W2132308708C2781018059 @default.
• W2132308708 hasConceptScore W2132308708C29537977 @default.
• W2132308708 hasConceptScore W2132308708C39845236 @default.
• W2132308708 hasConceptScore W2132308708C502942594 @default.
• W2132308708 hasConceptScore W2132308708C54355233 @default.
• W2132308708 hasConceptScore W2132308708C62112901 @default.
• W2132308708 hasConceptScore W2132308708C86803240 @default.
• W2132308708 hasIssue "5" @default.

• next